Coherus Oncology (CHRS) Intangibles: 2014-2025
Historic Intangibles for Coherus Oncology (CHRS) over the last 9 years, with Sep 2025 value amounting to $28.9 million.
- Coherus Oncology's Intangibles changed negligibly% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $28.9 million for FY2024, which is 31.08% down from last year.
- Latest data reveals that Coherus Oncology reported Intangibles of $28.9 million as of Q3 2025, which was down 0.00% from $28.9 million recorded in Q2 2025.
- In the past 5 years, Coherus Oncology's Intangibles registered a high of $41.9 million during Q4 2023, and its lowest value of $2.6 million during Q1 2021.
- Over the past 3 years, Coherus Oncology's median Intangibles value was $28.9 million (recorded in 2025), while the average stood at $30.3 million.
- Per our database at Business Quant, Coherus Oncology's Intangibles skyrocketed by 605.97% in 2023 and then tumbled by 31.08% in 2024.
- Over the past 5 years, Coherus Oncology's Intangibles (Quarterly) stood at $3.6 million in 2021, then soared by 66.46% to $5.9 million in 2022, then soared by 605.97% to $41.9 million in 2023, then slumped by 31.08% to $28.9 million in 2024, then remained steady at $28.9 million in 2025.
- Its Intangibles was $28.9 million in Q3 2025, compared to $28.9 million in Q2 2025 and $28.9 million in Q1 2025.